Omega3-fatty acid (Omacor) therapy for atrial fibrillation prevention after surgical myocardial revascularization (AXIOMA Study)
نویسندگان
چکیده
منابع مشابه
Does sodium nitroprusside decrease the incidence of atrial fibrillation after myocardial revascularization?: a pilot study.
BACKGROUND Atrial fibrillation (AF) often occurs after coronary artery bypass grafting and can result in increased morbidity and mortality. In the present pilot study, our aim was to investigate whether sodium nitroprusside (SNP), as a nitric oxide donor, can reduce the frequency of post-coronary artery bypass grafting AF. METHODS AND RESULTS To investigate the effectiveness of SNP in the pro...
متن کاملSurgical Therapy of Atrial Fibrillation
Atrial fibrillation (AF) can be found in an increasing number of cardiac surgical patients due to a higher patient's age and comorbidities. Atrial fibrillation is known, however, to be a risk factor for a greater mortality, and one aim of intraoperative AF treatment is to approximate early and long-term survival of AF patients to survival of patients with preoperative sinus rhythm. Today, surge...
متن کاملEarly surgical revascularization after acute myocardial infarction
Methods A total of 62 consecutive patients underwent CABG therapy within 14 days after the onset of myocardial infarction between September 2009 and January 2013 at our institution. Prospectively recorded preoperative, intraoperative, and postoperative data were retrospectively screened for in-hospital mortality and major adverse postoperative events (low cardiac output syndrome, prolonged mech...
متن کاملSurgical myocardial revascularization after acute infarction.
The records of 288 patients undergoing isolated surgical myocardial revascularization between June 1989 and September 1992 were reviewed to determine the relative risk associated with surgery after an acute myocardial infarction (MI). A total of 73 patients (25 percent) were operated on within 30 days of an acute infarction while 215 patients (75 percent) had no history of recent infarction. Pa...
متن کاملAtrial fibrillation after vardenafil therapy.
Vardenafil is a new oral phosphodiesterase inhibitor used for erectile dysfunction. We report a case admitted with a first-detected, symptomatic paroxysmal atrial fibrillation in a healthy patient after self-medication with vardenafil.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: "Arterial’naya Gipertenziya" ("Arterial Hypertension")
سال: 2008
ISSN: 2411-8524,1607-419X
DOI: 10.18705/1607-419x-2008-14-2-162-164